Interventional Oncology Devices Market Size- Industry Share, Growth, Trends and Forecast 2027

This report on the global Interventional Oncology Devices market gives a thorough study that is primarily focused on top players and their business stratagem, geographical extent, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is explicitly prepared to explore crucial fragments of the global Interventional Oncology Devices market. For instance, the market dynamics section in the report gives an in-depth analysis of the drivers, restraints, trends, and opportunities in the global Interventional Oncology Devices market. With both qualitative and quantitative analysis, we provide you with thorough and comprehensive information on the global Interventional Oncology Devices market. The study also entails SWOT, PESTLE, and Porter’s Five Forces analyses of the global Interventional Oncology Devices market. The global Interventional Oncology Devices Market is forecasted to be worth USD 3.11 Billion by 2027, according to a current analysis by Emergen Research.

Key Highlights From The Report

In September 2020, The strategic investment in Nanospectra Biosciences, Inc. was announced by Sirtex Medical Limited. The investment will offer funding to improve further Nanospectra 's leading prostate cancer tissue ablation device AuroLase, the first and only ultra-focal ablation treatment intended to enhance the efficiency of treatment, reducing adverse effects related to anesthesia, chemotherapy, and alternate focal therapies. In order to destroy solid cancer tumors, this treatment uses the company's patented AuroShells nanoparticle technique to minimize the damage of neighboring healthy tissue.

Over the forecasted timeline, the Embolization segment accounted for the largest market with a CAGR of 6.7%, since it is a minimally invasive therapy that offers advantages such as quick recovery, can be practiced through local anesthesia, and cost-effective.

It is anticipated that Bland Embolization or Transcatheter Arterial Embolization will expand significantly. This method is being used for the treatment of liver tumors or for postsurgical adjunctive treatment.

The segment of lung cancer will dominate the market during the forecasted period since smoking habits have increased the incidence of lung cancer.

Due to the rising prevalence of cancer, easy availability of interventional oncology, and the fast adoption of technological advancement owing to significant government spending on medical treatment, the North American region is expected to dominate the market.

Key participants include Sirtex Medical Limited, Teleflex Incorporated, Boston Scientific Corporation, INterface BIOmaterials B.V., Merit Medical Systems, Inc., BTG International Limited, IMBiotechnologies Ltd., IceCure Medical Ltd, HealthTronics, Inc., and Cook Medical Inc., among others.

You Can Download Free Sample PDF Copy of Interventional Oncology Devices Market at https://www.emergenresearch.com/request-sample/387

Product Type Outlook (Revenue, USD Billion; 2017-2027)

Support

Embolization

Ablation

Process Outlook (Revenue, USD Billion; 2017-2027)

Non-Thermal Tumor Ablation

Thermal Tumor Ablation

Transcatheter Arterial Radioembolization

Transcatheter Arterial Chemoembolization

Bland Embolization or Transcatheter Arterial Embolization

Cancer Type Outlook (Revenue, USD Billion; 2017-2027)

Lung Cancer

Liver Cancer

Bone Cancer

Breast Cancer

Prostate Cancer

Kidney Cancer

Others

Regional scope- North America; Europe; Asia Pacific; Central & South America; MEA

Table of Content

Chapter 1. Methodology & Sources

    1.1. Interventional Oncology Devices Market Definition

    1.2. Interventional Oncology Devices Market Research Scope

    1.3. Interventional Oncology Devices Market Methodology

    1.4. Research Sources

          1.4.1. Primary

          1.4.2. Secondary

          1.4.3. Paid Sources

    1.5. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2019-2027

Chapter 3. Key Insights

Chapter 4. Interventional Oncology Devices Market Segmentation & Impact Analysis

    4.1. Interventional Oncology Devices Market Material Segmentation Analysis

    4.2. Industrial Outlook

          4.2.1. Market indicators analysis

          4.2.2. Market drivers analysis

                    4.2.2.1. Increasing demand for emission-free commercial vehicles

                    4.2.2.2. Government support for Interventional Oncology Devicess

          4.2.3. Market restraints analysis

                    4.2.3.1. High development cost

    4.3. Technological Insights

    4.4. Regulatory Framework

    4.5. Porter’s Five Forces Analysis

    4.6. Competitive Metric Space Analysis

    4.7. Price trend Analysis

    4.8. Covid-19 Impact Analysis

Continued…